Delivery Order SPE2DB20D3103-SPE2DB22FP5S1
- Not listed
- This federal contract award is for the delivery of Amoxicillin-Clavulanate 875-125 mg tablets in 20-count packages to the Defense Logistics Agency (DLA). The $3,087.18 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 6, 2022 with a completion date of September 7, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This federal contract award is a $3,383.56 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of AMOX-CLAV 875-125 MG TABLET 100S, a pharmaceutical product, with a performance period through June 17, 2025. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,196.66 firm fixed-price delivery order is for the supply of Amoxicillin-Clavulanate 250-125 mg tablets, a commonly prescribed antibiotic medication. The contract has an ultimate completion date of October 26, 2022 and was awarded on October 25, 2022. This delivery order is part of a larger Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,543.50 firm fixed-price delivery order is for the supply of 4565751440 AMOX-CLAV 500-125 MG TABLET 20S. The contract has a completion date of September 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,265.87 delivery order is for the supply of Amox-Clav 875-125 mg tablets, a prescription medication. The contract has a firm-fixed price and an ultimate completion date of December 15, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,107.38 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Amoxicillin-Clavulanate 875-125 mg tablets (20 units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion date of August 27, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, supporting the company's role as a critical pharmaceutical distributor for federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,462.47 firm fixed-price delivery order is for the supply of 4563573481 - AMOXICILLIN 400 MG/5 ML SUSP 100ML, with a completion date of February 7, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award, valued at $1,511.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4560843903 AMOX-CLAV 875-125 MG TABLET 20S, a generic pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is May 8, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
- The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $7,032.05 contract is for the delivery of 20-count blister packs of Amox-Clav 875-125 mg tablets. This delivery order falls under an existing $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp as a single-award vehicle. The IDC serves as...
- The Defense Logistics Agency awarded a $2,092.43 delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Amoxicillin-Clavulanate 875-125 mg tablets in quantities of 20. This competitively awarded, firm fixed-price delivery order is set to be completed by June 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a small-value pharmaceutical procurement typical of routine medical supply...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FP5S1Delivery Order
This federal contract award, with ID SPE2DB20D3103|SPE2DB22FP5S1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $3,440.68 firm fixed-price delivery order is for the supply of 100 tablets of the drug Amoxicillin-Clavulanate 875-125 mg. This order falls under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the government to procure a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. This particular order does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, including the DLA and the Department of Justice Federal Bureau of Investigation, through large IDCs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 8/19/22 |